Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 6 |
| 1.1 List of Tables | 5 | 2 |
| 1.2 List of Figures | 7 | 1 |
| 2 Introduction | 8 | 1 |
| 2.1 Peripheral Transluminal Coronary Angioplasty Balloons Overview | 8 | 1 |
| 3 Products under Development | 9 | 6 |
| 3.1 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development | 9 | 1 |
| 3.2 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment | 10 | 1 |
| 3.3 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory | 11 | 1 |
| 3.4 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path | 12 | 1 |
| 3.5 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date | 13 | 1 |
| 3.6 Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials | 14 | 1 |
| 4 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products under Development by Companies | 15 | 4 |
| 4.1 PTCA Balloons Companies - Pipeline Products by Stage of Development | 15 | 2 |
| 4.2 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development | 17 | 2 |
| 5 Peripheral Transluminal Coronary Angioplasty Balloons Companies and Product Overview | 19 | 43 |
| 5.1 Aachen Resonance GmbH Company Overview | 19 | 1 |
| 5.1.1 Aachen Resonance GmbH Pipeline Products &Ongoing Clinical Trials Overview | 19 | 1 |
| 5.2 Acrostak (Schweiz) AG Company Overview | 20 | 1 |
| 5.2.1 Acrostak (Schweiz) AG Pipeline Products &Ongoing Clinical Trials Overview | 20 | 1 |
| 5.3 AlviMedica Medical Technologies Inc. Company Overview | 21 | 1 |
| 5.3.1 AlviMedica Medical Technologies Inc. Pipeline Products &Ongoing Clinical Trials Overview | 21 | 3 |
| 5.4 Andramed GmbH Company Overview | 24 | 1 |
| 5.4.1 Andramed GmbH Pipeline Products &Ongoing Clinical Trials Overview | 24 | 1 |
| 5.5 Atrium Medical Corporation Company Overview | 25 | 1 |
| 5.5.1 Atrium Medical Corporation Pipeline Products &Ongoing Clinical Trials Overview | 25 | 1 |
| 5.6 Bolton Medical, Inc. Company Overview | 26 | 1 |
| 5.6.1 Bolton Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 26 | 3 |
| 5.7 Boston Scientific Corporation Company Overview | 29 | 1 |
| 5.7.1 Boston Scientific Corporation Pipeline Products &Ongoing Clinical Trials Overview | 29 | 3 |
| 5.8 Cordis Corporation Company Overview | 32 | 1 |
| 5.8.1 Cordis Corporation Pipeline Products &Ongoing Clinical Trials Overview | 32 | 2 |
| 5.9 Hatch Medical, L.L.C. Company Overview | 34 | 1 |
| 5.9.1 Hatch Medical, L.L.C. Pipeline Products &Ongoing Clinical Trials Overview | 34 | 1 |
| 5.10 Innovia LLC Company Overview | 35 | 1 |
| 5.10.1 Innovia LLC Pipeline Products &Ongoing Clinical Trials Overview | 35 | 1 |
| 5.11 Lithotech Medical Ltd. Company Overview | 36 | 1 |
| 5.11.1 Lithotech Medical Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 36 | 1 |
| 5.12 M.A. Med Alliance SA Company Overview | 37 | 1 |
| 5.12.1 M.A. Med Alliance SA Pipeline Products &Ongoing Clinical Trials Overview | 37 | 1 |
| 5.13 Medinol Ltd. Company Overview | 38 | 1 |
| 5.13.1 Medinol Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 38 | 2 |
| 5.14 Medtronic plc Company Overview | 40 | 1 |
| 5.14.1 Medtronic plc Pipeline Products &Ongoing Clinical Trials Overview | 40 | 2 |
| 5.15 Meril Life Sciences Pvt. Ltd. Company Overview | 42 | 1 |
| 5.15.1 Meril Life Sciences Pvt. Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 42 | 2 |
| 5.16 MicroPort Scientific Corporation Company Overview | 44 | 1 |
| 5.16.1 MicroPort Scientific Corporation Pipeline Products &Ongoing Clinical Trials Overview | 44 | 3 |
| 5.17 Natec Medical Ltd Company Overview | 47 | 1 |
| 5.17.1 Natec Medical Ltd Pipeline Products &Ongoing Clinical Trials Overview | 47 | 1 |
| 5.18 Pressure Products, Inc. Company Overview | 48 | 1 |
| 5.18.1 Pressure Products, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 48 | 1 |
| 5.19 QT Vascular Ltd. Company Overview | 49 | 1 |
| 5.19.1 QT Vascular Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 49 | 6 |
| 5.20 QualiMed Innovative Medizinprodukte GmbH Company Overview | 55 | 1 |
| 5.20.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products &Ongoing Clinical Trials Overview | 55 | 1 |
| 5.21 Revma, Inc. Company Overview | 56 | 1 |
| 5.21.1 Revma, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 56 | 1 |
| 5.22 The Spectranetics Corporation Company Overview | 57 | 1 |
| 5.22.1 The Spectranetics Corporation Pipeline Products &Ongoing Clinical Trials Overview | 57 | 2 |
| 5.23 TissueGen, Inc. Company Overview | 59 | 1 |
| 5.23.1 TissueGen, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 59 | 2 |
| 5.24 VasoTech Inc. Company Overview | 61 | 1 |
| 5.24.1 VasoTech Inc. Pipeline Products &Ongoing Clinical Trials Overview | 61 | 1 |
| 6 Peripheral Transluminal Coronary Angioplasty Balloons- Recent Developments | 62 | 30 |
| 6.1 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services | 62 | 1 |
| 6.2 Aug 30, 2016: MPSC Announces 2016 Interim Results | 63 | 1 |
| 6.3 Aug 25, 2016: Medtronic Reports First Quarter Financial Results | 64 | 2 |
| 6.4 Aug 22, 2016: Replacement of President &CEO Getinge Group:Joacim Lindoff appointed Acting President &CEO of Getinge Group | 66 | 1 |
| 6.5 Aug 22, 2016: Joacim Lindoff appointed Acting President &CEO of Getinge Group | 67 | 1 |
| 6.6 Aug 10, 2016: Spectranetics Receives CE Mark for AngioSculptX | 67 | 1 |
| 6.7 Aug 09, 2016: Neovasc Reports Second Quarter Results for 2016 | 67 | 3 |
| 6.8 Jul 28, 2016: Spectranetics Reports Second Quarter 2016 Revenue of $67.7 million | 70 | 1 |
| 6.9 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 | 71 | 1 |
| 6.10 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results | 72 | 2 |
| 6.11 Jul 25, 2016: QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment | 74 | 1 |
| 6.12 Jul 21, 2016: Firefighter PTCA Balloon Dilatation Catheter Granted CE Mark | 74 | 1 |
| 6.13 Jul 21, 2016: Federal Circuit Court Rules in Appeal | 75 | 1 |
| 6.14 Jul 14, 2016: Getinge Interim Report January-June 2016 | 75 | 1 |
| 6.15 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors | 75 | 1 |
| 6.16 Jul 05, 2016: Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements | 76 | 1 |
| 6.17 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic | 76 | 1 |
| 6.18 Jun 27, 2016: QT Vascular Receives FDA 510(k) Clearance For Chocolate XD, A Novel PTCA Balloon | 77 | 1 |
| 6.19 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation | 77 | 1 |
| 6.20 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day | 78 | 1 |
| 6.21 Jun 03, 2016: Getinge Group appoints Jens Viebke as new President of Acute Care Therapies Business Category Unit | 78 | 1 |
| 6.22 Jun 03, 2016: LEPUCARE established in India | 79 | 1 |
| 6.23 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results | 79 | 3 |
| 6.24 Apr 01, 2016: MicroPort and Yizheng Municipal Government Establishes "Shanghai-Yizheng Healthcare Cooperation Project" | 82 | 1 |
| 6.25 Mar 29, 2016: Getinge Group Receives Innovative Technology Designation from Novation for the Maquet InterValve V8 Balloon Aortic Valvuloplasty Catheter | 82 | 1 |
| 6.26 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device | 83 | 1 |
| 6.27 Feb 29, 2016: FOXTROT PRO Gains Market Approval in Indonesia | 83 | 1 |
| 6.28 Feb 25, 2016: Spectranetics Achieves Fourth Quarter 2015 Revenue of $65.2 Million | 83 | 1 |
| 6.29 Feb 23, 2016: Lepu Medical Amends Private Placement of Shares for USD110 Million | 84 | 1 |
| 6.30 Feb 11, 2016: QT Vascular Announces Another Positive Outcome in Litigation with Spectranetics/Angioscore | 84 | 1 |
| 6.31 Feb 10, 2016: QT Vascular Announces Another Positive Outcome in Litigation with Spectranetics/Angioscore | 85 | 1 |
| 6.32 Feb 01, 2016: TE Connectivity to Acquire Creganna Medical from Permira Advisers for USD895 Million | 85 | 1 |
| 6.33 Jan 21, 2016: NC Tadpole Obtained CFDA Registration Certificate | 86 | 1 |
| 6.34 Jan 05, 2016: QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon | 86 | 1 |
| 6.35 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved | 87 | 1 |
| 6.36 Dec 23, 2015: MicroPort Completed the First Distant Interactive Surgery in the Field of Coronary Interventional Treatment | 87 | 1 |
| 6.37 Dec 17, 2015: OrbusNeich demonstrates Sapphire II Coronary Dilatation Catheter at GulfPCR-GIM 2015 | 88 | 1 |
| 6.38 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International Conference | 88 | 2 |
| 6.39 Nov 26, 2015: Two Subsidiaries of MicroPort Recognized as One of Shanghai's the First Group of High-tech Enterprise | 90 | 1 |
| 6.40 Nov 18, 2015: Major Expansion for Creganna Medical, Minnesota | 90 | 1 |
| 6.41 Oct 28, 2015: CITIC Private Equity Funds Management to Acquire Biosensors International | 91 | 1 |
| 7 Appendix | 92 | 4 |
| 7.1 Methodology | 92 | 2 |
| 7.2 About GlobalData | 94 | 1 |
| 7.3 Contact Us | 94 | 1 |
| 7.4 Disclaimer | 95 | 1 |
